Elatrash, Citrine
Macke, Colleen
Shi, Jenna
Wilson, Theresa
Elsea, Sarah H.
Sisley, Stephanie
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD106345)
Article History
Received: 30 September 2025
Accepted: 26 December 2025
First Online: 13 January 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board at Baylor College of Medicine. All subjects provided verbal consent. Clinical trial number: not applicable.
: Not applicable.
: Both SHE and SS have received research and consulting funds from Rhythm Pharmaceuticals. SS has also received research funds from NIH and Eli Lilly and Company. SHE has research funding from the NIH, PTC Therapeutics, Speragen, Inc, and PRISMS, Inc. PRISMS, Inc. supports the SMS Patient Registry, which is housed at Baylor College of Medicine. All other authors declare no conflicts of interest.